Glancy prongay & murray llp, a leading securities fraud law firm, announces investigation of acelrx pharmaceuticals, inc. (acrx) on behalf of investors

Los angeles--(business wire)---- $acrx #classaction--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of acelrx pharmaceuticals, inc. (“acelrx” or the “company”) (nasdaq: acrx) investors concerning the company's possible violations of the federal securities laws. if you suffered a loss on your acelrx investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secur
ACRX Ratings Summary
ACRX Quant Ranking